Protecting Sleep Hygiene in the PICU: A Quality Improvement Project.

To increase the number of nights without sleep interruptions for routine tasks in recovering PICU patients. Prospective quality improvement project. Single-center, free-standing, tertiary children's hospital. Patients admitted to the PICU for greater than 72 hours and eligible for early mobilization. A multidisciplinary sleep hygiene team was created to improve sleep hygiene in critically ill patients eligible for early mobilization. This team rewrote local nursing policies to avoid routine tasks between 11 pm and 5 am . The team provided periodic control chart updates to staff detailing progress made protecting sleep. Discussions of sleep hygiene were added to the daily goal sheet and a sleep hygiene order set was created. Finally, the PICU quality dashboard was modified to show whether a sleep hygiene order set was initiated in eligible patients. Routine tasks were defined as daily chest radiographs, baths, routine tracheostomy care, central line dressing changes, twice daily medications, weights, and Foley care. After a year of data collection, avoidance of routine pupillary examinations was added to the sleep protection criteria. Baseline data was collected for 2 months prior to the creation of the sleep hygiene team. Screening of eligible patients occurred 1 week each month. The data were analyzed utilizing control charts. Baseline data demonstrated 32% of PICU patients without sleep interruptions. The centerline increased to 58% after the initial interventions but dropped to 33% after inclusion of pupillary checks. Following the introduction of the daily goal sheet, sleep hygiene order set, and tracking on the quality board, 49% of patients went without interruptions. The initiation of a sleep hygiene team along with retiming routine tasks, daily discussions on rounds with the daily goal sheet, introduction of a sleep hygiene order set, and transparent tracking improved the percentage of patients with protected sleep.

Informations de copyright

Copyright © 2023 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Déclaration de conflit d'intérêts

Dr. Bhattarai received funding through stocks from Decibel Therapeutics, Nuance Communications, Supernus Pharmaceuticals, Inovio Pharmaceuticals, TFF Pharmaceuticals, Galera Therapeutics, Bristol-Myers Squibb, CVS Health, Cardinal Health, Gilead Sciences, Novavax, Quest Diagnostics, and Teladoc. The remaining authors have disclosed that they do not have any potential conflicts of interest.